Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...
The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...
The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...
The FDA is in the middle of “an epic struggle” with the tobacco ... “I’ve always been a vaccine believer, but the Covid vaccine reinforced to me that there may be long-term benefits to vaccination ...
The Food and Drug Administration (FDA) is placing a hold on Novavax's (NVAX) experimental flu-COVID vaccines after a patient ...
Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...
The clinical hold is due to a spontaneous report of a serious adverse event (SAE) of motor neuropathy in a single CIC Phase 2 trial participant outside the U.S. who received the vaccine in January ...